what is microdosing for glp 1 THE PCCA BLOG Thinking About Microdosing GLP-1? 5

In vitro DDI studies detailed in clinical pharmacology and biopharmaceutics reviews were not included for exenatide and dulaglutide, but were included for liraglutide, semaglutide, and tirzepatide (Table 3)

While the exact mechanisms remain unclear, several factors are implicated, including nutritional aspects, mechanical unloading, loss of lean mass, and alterations in the secretion of gut hormones and adipokines [8, 10]

Clinical studies show that semaglutide GLP-1 can help people lose an average of 15% of their initial body weight over around 68 weeks

possibly, pharmacological treatment must be lifelong [74]